Oral 8: Bone & minerals

[O8-1] Clinical Trial of Asfotase Alfa in Patients with Hypophosphatasia (HPP) in Japan

^○Taichi Kitaoka¹, Toshihiro Tajima², Keisuke Nagasaki³, Toru Kikuchi³, Katsusuke Yamamoto⁴, Toshimi Michigami⁵, Satoshi Okada⁶, Ikuma Fujiwara⁷, Masayuki Kokaji⁸, Hiroshi Mochizuki⁹, Tsutomu Ogata¹⁰, Koji Tatebayashi¹¹, Atsushi Watanabe¹², Shuichi Yatsuga¹³, Takuo Kubota¹ (1.Department of Pediatrics, Osaka University Graduate School of Medicine, 2.Department of Pediatrics, Hokkaido University School of Medicine, 3.Division of Pediatrics / Department of Homeostatic Regulation and Development, Niigata University Graduate School of Medical and Dental Sciences, 4.Department of Pediatric Nephrology and Metabolism, Osaka Medical Center and Research Institute for Maternal and Child Health, 5.Department of Bone and Mineral Research, Osaka Medical Center and Research Institute for Maternal and Child Health, 6.Department of Pediatrics, Hiroshima University Graduate School of Biomedical & Health Sciences, 7.Department of Pediatrics, Tohoku University School of Medicine, 8.Department of Pediatrics, Showa General Hospital, 9.Division of Endocrinology and Metabolism, Saitama Children’s Medical Center, 10.Department of Pediatrics, Hamamatsu University School of Medicine, 11.Department of Pediatrics, Nagara Medical Center, 12.Division of Clinical Genetics, Nippon Medical School Hospital, 13.Department of Pediatrics and Child Health, Kurume University School of Medicine)